The COMPACT SURVEY started in November 2011. At the occasion of the ASN congress in Philadelphia, USA, 38 healthcare professionals participated and the overall results so far have been analyzed:
- The participating physicians are convinced that dialysis patients do not know about the consequences of hyperphosphatemia and that this is the foremost reason for noncompliance.
- The physicians know about the high pill burden of their patients and do rank this as one of the major problems when it comes to therapy adherence.
- In the eyes of the physicians the best way to raise the awareness of patients towards the lifelong consequences of hyperphosphatemia is the personal conversation with a healthcare professional.
- Brochures and online channels are not deemed as effective.
- Physicians do agree, that serum phosphorous is the most important parameter for achieving good results in hyperphosphatemia therapy and that treatment should be started at a phosphorous level of 4.5 to 5.5 mg/dl.